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Invariant natural killer T (iNKT) cells promote immune
responses to various pathogens, but exactly how
iNKT cells control antiviral responses is unclear.
Here, we showed that iNKT cells induced tissue-
specific antiviral effects in mice infected by lympho-
cytic choriomeningitis virus (LCMV). Indeed, iNKT
cells inhibited viral replication in the pancreas and
liver but not in the spleen. In the pancreas, iNKT cells
expressed the OX40 molecule and promoted type I
interferon (IFN) production by plasmacytoid dendritic
cells (pDCs) through OX40-OX40 ligand interaction.
Subsequently, this iNKT cell-pDC cooperation atten-
uated the antiviral adaptive immune response in the
pancreas but not in the spleen. The dampening of
pancreatic anti-LCMV CD8+ T cell response pre-
vented tissue damage in transgenic mice expressing
LCMV protein in islet b cells. Thus, this study iden-
tifies pDCs as an essential partner of iNKT cells for
mounting an efficient, nondeleterious antiviral
response in peripheral tissue.INTRODUCTION
Natural killer T (NKT) cells are innate-like T lymphocytes that are
found in rodents and primates. They can influence a wide array of
immune responses (Bendelac et al., 2006). NKT cells are
nonconventional T cells restricted by the CD1d molecule that
presents self and exogenous glycolipids (Kinjo et al., 2006; Matt-
ner et al., 2005; Zhou et al., 2004). Most NKT cells express an
invariant TCRa chain (Va14-Ja18 [Va14] in mice and Va24-
Ja18 in humans). NKT cells also express several markers of
the NK lineage and have an activated or memory phenotype.
They are unique in their ability to promptly secrete copious
amounts of cytokines, such as IFN-g and IL-4. Once activated,NKT cells can provide maturation signals to downstream cells,
including dendritic cells, NK cells, and lymphocytes, thereby
contributing to both innate and acquired immunity (Bendelac
et al., 2006; Kronenberg, 2005). Accordingly, NKT cells can influ-
ence diverse immune responses, including tumor surveillance,
anti-infectious defenses, and maintenance of self-tolerance
(Brigl and Brenner, 2004).
NKT cells have been implicated in natural responses to para-
sites, bacteria, and viruses (Bendelac et al., 2006; Brigl and
Brenner, 2004). Studies performed with NKT cell-deficient mice
(CD1d-deficient mice devoid of all NKT cells or Ja18/ mice
specifically lacking iNKT cells) have shown that iNKT cells are
critical for the clearance of various pathogens. During bacterial
infections, iNKT cells can be activated either indirectly, by IL-12
produced by lipopolysaccharide-stimulated dendritic cells, or
directly, by bacterial lipid antigens presented by CD1d. Although
viruses do not contain lipid antigens, NKT cells have also been
implicated in antiviral responses. NKT cell deficiency enhances
viral load during encephalomyocarditis virus (EMCV) infection
(Ilyinskii et al., 2006) and herpes simplex virus type 1 and 2 infec-
tion (Grubor-Bauk et al., 2003). NKT cells contribute to the innate
response against herpes simplex virus type 2 by producing large
amounts of IFN-g (Ashkar and Rosenthal, 2003), and they also
promote adaptive immune responses to viruses; for example,
they augment specific CD8+ T cell responses to respiratory
syncytial virus (Johnson et al., 2002). Studies on the antibacterial
role of iNKT cells have highlighted their functional cooperation
with dendritic cells (Brigl et al., 2003; Kinjo et al., 2005; Tupin,
2007; Mattner et al., 2005), but little is known of the interaction
between these cell types during viral infection.
NKT cells have also been implicated in the regulation of auto-
immune diseases, such as multiple sclerosis and type 1 diabetes
(Mars et al., 2004). Studies using mouse models have shown that
iNKT cells can inhibit the development of type 1 diabetes by im-
pairing the differentiation of T helper 1 (Th1) anti-islet T cells and/
or by recruiting tolerogenic myeloid dendritic cells (Beaudoin
et al., 2002; Chen et al., 2005; Naumov et al., 2001). Converging
epidemiological and functional studies suggest that viralImmunity 30, 289–299, February 20 , 2009 ª2009 Elsevier Inc. 289
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NKT Cells and pDCs Control Antiviral Responsesinfections could play a role in the onset of type 1 diabetes (Dotta
et al., 2007; Knip et al., 2005; von Herrath et al., 2003). However,
it is unclear whether NKT cells could both enhance antiviral
immunity and prevent autoimmune responses at the same time
during virus-induced diabetes.
To analyze the influence of NKT cells on antiviral responses, as
well as the cellular mechanisms involved in these responses, we
used mice lacking NKT cells (CD1d-deficient or Ja18-deficient)
(Mendiratta et al., 1997; Zhu et al., 2007), as well as transgenic
mice containing an elevated frequency of iNKT cells (Va14)
(Lehuen et al., 1998) and mice treated with a-galactoside ceram-
ide (a-GalCer), an iNKT cell agonist (Kawano et al., 1997). Upon
lymphocytic choriomeningitis virus (LCMV) infection, we found
that iNKT cells exerted different antiviral functions in different in-
fected tissues: in particular, they inhibited early virus replication
in the pancreas and liver but had no influence on early splenic
Figure 1. iNKT Cells Inhibit LCMV Replication in the Pancreas
and the Liver But Not in the Spleen
(A) The spleen and pancreas were harvested on various days after LCMV
Arm challenge (105 pfu), and virus titers were determined. The dotted line
across the graphs represents the detection limit. Each dot corresponds to
the mean ± SD of the values obtained with four individual mice.
(B and C) Comparison of viral titers on day 3 after LCMV Arm infection (105
pfu) of NOD and C57BL/6 mice untreated or treated with a-GalCer.
(D) Comparison of viral titers on day 3 after LCMV Arm infection (104 pfu)
of NOD Va14 Tg, CD1d-deficient, or Ja18-deficient NOD mice.
(E) Comparison of viral titers in the liver on days 2 and 4 after LCMV WE
infection (102 pfu) of control and Va14 Tg mice.
In (B–E), each bar corresponds to the mean ± SD of the values obtained in
3–5 independent experiments, each performed with three individual mice
per group. Asterisk indicates p values < 0.05, compared to control NOD or
C57BL/6 mice.
viral load. The local iNKT cell-mediated innate antiviral
response required plasmacytoid dendritic cell (pDC) cooper-
ation. Furthermore, stimulation of innate responses by iNKT
cells influenced adaptive anti-LCMV CD8+ T cell responses
in the pancreas, thereby preventing virus-induced tissue
damage, in transgenic mice expressing LCMV protein in islet
b cells.
RESULTS
iNKT Cells Inhibit LCMV Replication in the Pancreas
and the Liver But Not in the Spleen
To investigate the role of iNKT cells in antiviral responses, we
first assessed the influence of these cells on LCMV replication
and clearance in various lymphoid and nonlymphoid tissues
(spleen, pancreas, and liver). Kinetic studies of virus replica-
tion after primary infection in Va14 Tg mice overexpressing
iNKT cells showed that, although LCMV replication was
unchanged in the spleen relative to normal mice, LCMV repli-
cation was markedly inhibited in the pancreas (99.9%) as
early as one day after infection (Figure 1A). In contrast, iNKT
cells promoted later (days 6 and 8) virus clearance from the
spleen of Va14 Tg mice. The effect of iNKT cells on pancreatic
LCMV replication was confirmed in another model on the
basis of iNKT cell activation by a-GalCer, in both NOD and
C57BL/6 mice (Figures 1B and 1C).
To demonstrate the involvement of iNKT cells in the control of
LCMV replication in normal mice, we used CD1d-deficient and
Ja18-deficient mice that lack this cell type. A marked increase
in pancreatic viral load was observed in these mice devoid of
iNKT cells, even when a lower LCMV inoculum was used (104
pfu) (Figure 1D). We then used the hepatotropic LCMV WE strain
to analyze the role of iNKT cells in the liver (Dutko and Oldstone,
1983). As observed in the pancreas, iNKT cells inhibited viral
replication in the liver as early as two days after infection
(Figure 1E). Together, these results show that iNKT cells can
rapidly control pancreatic and hepatic viral load, but not splenic
viral load, early after LCMV infection.
iNKT Cell Behavior during LCMV Infection
Because iNKT cells were found to have a major impact on LCMV
replication in the pancreas, we examined the behavior of iNKT290 Immunity 30, 289–299, February 20 , 2009 ª2009 Elsevier Inc.
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staining of splenocytes and pancreas-infiltrating cells in the
absence of infection confirmed that CD1d-deficient NOD mice
were deficient in iNKT cells (<0.1%), whereas Va14 Tg NOD
mice contained an elevated frequency of iNKT cells as compared
to control mice (Figure 2A). Two days after LCMV challenge, the
iNKT cell frequency and absolute number were both reduced in
the spleen and pancreas of control and Va14 Tg mice
(Figure 2B). Cytokine production by iNKT cells was analyzed 4,
8, 12, 24, and 48 hr after infection. Although splenic iNKT cells
produced both IFN-g and IL-4 at 12 and 24 hr after infection
(Figure 2C and data not shown), we detected no cytokine
production by pancreatic iNKT cells. In contrast, the expression
of activation markers such as CD69, CD25, and CD44 was
increased on iNKT cells from both tissues upon LCMV infection
(Figure 2D). Thus, iNKT cells are differently activated in the
spleen and pancreas after LCMV infection.
iNKT Cells Enhance the pDC Response in the Pancreas
To determine the cellular mechanism by which iNKT cells inhibit
pancreatic viral replication, we investigated the effect of iNKT
cells on the function of pDCs, an important cell subset involved
in the innate immune response against viruses (Barchet et al.,
2005). In the pancreas, contrary to the spleen, the pDC
frequency increased sharply within 1 day after LCMV infection
Figure 2. INKT Cell Behavior during LCMV
Infection
The spleen and pancreas were harvested from
both types of mice before and one or two days
after LCMV Arm infection and a-GalCer treatment.
(A and B) Cells were stained with TCR-b mAb and
CD1d:a-GalCer tetramers. Each dot or bar corre-
sponds to the mean value ± SD obtained with six
individual mice. Asterisk indicates p < 0.05,
compared to day 0 group.
(C) Cytokine expression by iNKT cells, 24 hr after
LCMV infection, was evaluated by intracellular
staining with IL-4 and IFN-gmAbs. Data are repre-
sentative of three independent experiments, each
performed with three pooled mice per group.
(D) Expression of activation markers on iNKT cells
was determined by staining with CD69, CD25, and
CD44 mAbs. Each bar corresponds to the mean ±
SD of values obtained in three independent exper-
iments, each performed with three individual mice
per group. Asterisk indicates p value < 0.05,
compared to day 0 group.
(Figure 3A). Importantly, on day 3, this
increase in the pancreatic pDC frequency
was significantly larger in Va14 Tg mice
and in a-GalCer-treated mice than in
untreated control mice (Figures 3A–3C).
Conversely, the pDC frequency in the
pancreas of CD1d-deficient and Ja18-
deficient mice was markedly decreased,
3 days after infection, as compared to
control mice (Figures 3B and 3C). Of
note, the frequency of pDCs in the spleen was not influenced
by iNKT cells, because the same frequency was observed in
the four types of mice (Figures 3A–3C). Given that pDCs are
characterized by their capacity to produce large amounts of
type I IFN (IFN-a and IFN-b) after viral stimulation, we examined
type I IFN production by these cells in the pancreas and spleen
after LCMV challenge. In the pancreas, infection induced type I
IFN production by pDCs, and this production was 2-fold higher
in Va14 Tg mice and a-GalCer-treated mice than in control
mice (Figures 3D and 3E). pDCs produced little type I IFN in
the spleen of the three types of mice, despite being present
in significant numbers. Of note, no type I IFN production by
splenic pDCs was detected before infection, and the number
of pDCs in the pancreas of noninfected mice was too small
to allow analysis of type I IFN production (Figure S1A, available
online). The increase in antiviral cytokine production in the
pancreas of Va14 Tg mice upon infection was also observed
at the transcriptional level (Figure S1B). For demonstration of
the key role of pDCs in the control of pancreatic viral replica-
tion, pDCs were depleted by mAb 120G8 treatment
(Figure 3F, left panel). pDC depletion led to a marked increase
in pancreatic viral load in both control and Va14 Tg mice
(Figure 3F, right panel). Together, these results show that,
in the pancreas, iNKT cells promote pDC control of LCMV
replication.Immunity 30, 289–299, February 20 , 2009 ª2009 Elsevier Inc. 291
Immunity
NKT Cells and pDCs Control Antiviral ResponsesThe OX40-OX40L Pathway Is Required for iNKT
Cell-pDC Cooperation in the Pancreas
Even though we did not detect IFN-g production by pancreatic
iNKT cells upon LCMV Arm infection, treatment with a blocking
IFN-gmAb was used for ruling out a role of IFN-g in the enhanced
type 1 IFN production by pDCs (Figure 4A). This treatment did
not influence the production of type I IFN by pDCs in the
pancreas upon infection. To determine whether other molecules
expressed by pancreatic iNKT cells could be involved in the acti-
vation of pDCs, we compared the phenotype of iNKT cells from
the pancreas, spleen, and pancreatic lymph nodes (PLN). The
OX40 molecule was strongly and specifically expressed on
iNKT cells in pancreatic islets as compared to both lymphoid
tissues, and OX40 expression on pancreatic iNKT cells was up-
regulated upon LCMV infection (Figure 4B). Interestingly, OX40
was also expressed by iNKT cells in the liver (Figure S2), a tissue
in which iNKT cells efficiently control LCMV WE replication
(Figure 1E). The role of OX40-OX40L in the crosstalk between
pancreatic iNKT cells and pDCs that express OX40L (Ito et al.,
2004 and data not shown) was first explored by use of an
Figure 3. iNKT Cells Enhance pDC Accumulation
and Function in the Pancreas
(A–C)The spleen and pancreas were harvested from
control and Va14 Tg mice (A and B), CD1d-deficient
mice (B, day 3), a-GalCer-treated mice, and Ja18-defi-
cient mice (C, day 3) on various days after LCMV Arm
infection. Cells were stained with CD11c mAb and mAb
120G8. The results correspond to the mean ± SD of values
obtained in four independent experiments, each per-
formed with two pooled mice. Asterisk indicates p <
0.05, compared to control mice. Note that data in (A)
and (C) represent pDC percentage among CD11c+ cells
and that data in (B) represent pDC percentage among
live cells.
(D) The spleen and pancreas were harvested from control,
Va14 Tg, or a-GalCer-treated mice two days after infec-
tion. Cells were stained with IFN-a and IFN-b mAbs for
measurement of intracellular expression in 120G8hiCD11clo
cells. The results correspond to the mean ± SD of the
values obtained in four independent experiments, each
performed with three pooled mice per group.
(E) Absolute number of type I IFN+ pDCs on day 2 after
infection. Asterisk indicates p < 0.05, compared to control
mice.
(F) Frequency of DCs (left panel) and viral titers (right
panel) in the pancreas on day 3 after infection of mice
untreated or treated with mAb 120G8. Similar DC frequen-
cies were obtained in two independent experiments. Viral
titers correspond to the mean ± SD of the values obtained
in three independent experiments, with three individual
mice per group in each experiment.
OX40L mAb, which abrogates the OX40-
OX40L pathway (Malmstrom et al., 2001)
without depleting OX40L+ pDCs (Figure S3).
This treatment greatly reduced the production
of type I IFN by pancreatic pDCs upon LCMV
infection of control, a-GalCer-treated, and
Va14 Tg mice (Figure 4C). Consequently,
blockade of the OX40-OX40L interaction
increased pancreatic viral load in OX40L mAb-
treated Va14 Tg mice (Figure 4D). The critical role of the OX40
molecule in pDC activation by iNKT cells in the pancreas was
confirmed by reconstitution of OX40-deficient mice with sorted
iNKT cells expressing or not expressing the OX40 molecule
(Figure 4D). Reconstitution of OX40-deficient mice with wild-
type (WT) iNKT cells, but not with OX40-deficient iNKT cells,
significantly reduced viral load in the pancreas.
To demonstrate that OX40-OX40L interaction is required for
direct iNKT-pDC cooperation, cocultures were performed with
sorted cell populations (Figure 5A). In the presence of LCMV,
pDC-iNKT cell interaction resulted in IFN-a production only
when iNKT cells were isolated from the pancreas and not from
the spleen. Importantly, this type I IFN production was abolished
by the addition of OX40L mAb or soluble mouse OX40-Ig fusion
molecule to the culture. These experiments demonstrated that
specific cooperation between pDCs and pancreatic iNKT cells
required OX40-OX40L interaction. In contrast to OX40L, CD1d
expression by pDCs (Figure S4) was not crucial for efficient inter-
action between iNKT cells and pDCs, because equal amounts of
IFN-a were produced in cultures with WT and CD1d-deficient292 Immunity 30, 289–299, February 20 , 2009 ª2009 Elsevier Inc.
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iNKT cells and pDCs cooperate through OX40-OX40L interac-
tion to produce type I IFN.
iNKT Cell-pDC Cooperation Controls Anti-LCMV CD8
Responses in the Pancreas
Given that viral infection induces strong adaptive CD8+ T cell
responses, we then examined whether iNKT cells could influ-
ence this response, as well as subsequent tissue damage, by
using transgenic mice expressing LCMV nucleoprotein (NP) in
b cells under the control of the insulin promoter (Ins-NP mice).
This is a well-established model used for the study of virus-
specific CD8+ T cell responses and their deleterious effect in
the pancreas (Ohashi et al., 1991; Oldstone et al., 1991; von Her-
rath et al., 1994). Anti-LCMV CD8+ T cell responses were evalu-
ated in terms of IFN-g production after in vitro stimulation with
LCMV NP396 peptide. Although iNKT cells enhanced the anti-
LCMV CD8+ T cell response on days 6 and 8 in the spleen,
they markedly reduced this response in the pancreas (Figures
6A and 6B; Figure S5), indicating a divergent, site-dependent
role for iNKT cells. Similar results were obtained with Ins-NP
mice, as well as with NP-negative mice (Figures 6A and 6B).
This dampening of the pancreatic anti-LCMV CD8+ T response
by iNKT cells was further confirmed by transfer of a large number
of iNKT cells into Ins-NP control mice before infection
(Figure 6C).
To explore the role of pDCs and OX40-OX40L molecules in the
regulation of anti-LCMV CD8+ adaptive response by iNKT cells,
mAbs were used either to deplete pDCs or to block OX40-OX40L
interaction in Va14 Tg and a-GalCer-treated mice. Both pDC
depletion and blockade of OX40-OX40L interaction restored
a strong anti-LCMV CD8+ T cell response in the pancreas of
Va14 Tg and a-GalCer-treated mice (Figure 6D). To confirm the
influence of the anti-LCMV innate response, as well as subse-
quent virus replication, on the adaptive response, control and
Va14 Tg mice received various inocula designed to generate
different levels of pancreatic viral load (Figure 6E). Inoculation
of control mice with 104 pfu (instead of 105 pfu used in the
previous experiments) led to a lower pancreatic viral titer on
day 3 and to a lower frequency of IFN-g+ anti-LCMV CD8+
T cells. By contrast, viral challenge with 106 pfu/mouse appeared
to overcome the iNKT cell-mediated innate response in the
pancreas, because the viral titer was similar in control and
Va14 Tg mice on day 3. Importantly, with this large viral inoc-
ulum, a strong adaptive anti-LCMV CD8+ T cell response was
induced in the pancreas of both types of mice, showing a strong
link between the pancreatic LCMV titer and the development of
the adaptive response after LCMV infection. Together, these
experiments confirmed the critical role of iNKT cell-pDC cooper-
ation for the control of both innate and adaptive immune
responses to LCMV.
iNKT Cell-pDC Cooperation Prevents Tissue Damage
in a Model of LCMV-Induced Diabetes
To examine the functional consequences of low effector anti-
LCMV CD8+ T responses in the pancreas, we examined whether
iNKT cells could also prevent pancreatic damage and diabetes in
Ins-NP mice after LCMV infection (Figures 7A and 7B, left panel).
Although most infected control animals developed massive
pancreatic cell infiltration leading to severe insulitis and glucosu-
ria, none of 30 Va14 Tg mice and one of 30 a-GalCer-treated
mice became diabetic, in line with the lesser islet infiltration in
Figure 4. The OX40-OX40L Pathway Is Required for In Vivo
Pancreatic pDC and iNKT Cell Cooperation
(A) The pancreas was harvested two days after infection from control and
Va14 Tg mice treated or untreated with IFN-g mAb. Cells were stained
with IFN-a and IFN-bmAbs mAbs for measurement of intracellular expres-
sion in 120G8hiCD11clow cells. Results are the mean ± SD of the values
obtained in three experiments, with three pooled mice per group.
(B) The spleen, PLN, and pancreas were harvested from mice before
(day 0) and two days after LCMV Arm infection. Cells were stained with
TCR-b mAb, CD1d:a-GalCer tetramer, and OX40 mAb. Results corre-
spond to the mean ± SD of the values obtained in four independent exper-
iments, with three pooled mice for each group. Asterisk indicates p < 0.05
for pancreatic iNKT cells between infected and uninfected mice.
(C) Cells from pancreatic islets two days after infection of mice untreated
or treated with OX40L mAb were stained with 120G8, CD11c, IFN-a, and
IFN-bmAbs mAbs. Results correspond to the mean ± SD of the values ob-
tained in four independent experiments, with three pooled mice for each
group. Asterisk indicates p < 0.05 between mAb treated and untreated
mice.
(D) LCMV titers were determined on day 3 after infection, in the pancreas
of NOD mice untreated or treated with OX40L mAb or in OX40-deficient
C57BL/6 mice reconstituted with syngeneic WT or OX40-deficient iNKT
cells. Results are the mean ± SD of the values obtained in 2–4 independent
experiments, with three individual mice per group. Asterisk indicates
p < 0.05, as indicated in the figure.Immunity 30, 289–299, February 20 , 2009 ª2009 Elsevier Inc. 293
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tions in the three types of Ins-NP mice revealed similar frequency
of B cells, CD4+ T cells, or CD8+ T cells (Figure S6). The protec-
tive role of iNKT cells was further demonstrated with the use of
CD1d-deficient Ins-NP mice, all of which developed diabetes
after challenge with 104 pfu, as compared to only half the control
Ins-NP mice and no Va14 Tg Ins-NP mice (Figure 7B, right panel).
The role of pDCs and OX40-OX40L interaction was further
demonstrated by treatment with mAbs that deplete pDCs or
block OX40-OX40L interaction, because this abolished the
protective role of iNKT cells against pancreatic damage in
Va14 Tg and a-GalCer-treated Ins-NP mice (Figure 7C).Thus,
iNKT cell-pDC interaction through OX40-OX40L is critical for
avoiding pancreatic islet destruction upon viral infection.
DISCUSSION
NKT cells have a dual role in the regulation of immune responses.
Altough they promote T cell responses against pathogens
(Bendelac et al., 2006), NKT cells usually dampen T cell
responses against self antigens (Mars et al., 2004). Here, we
demonstrate that iNKT cells can also play both regulatory roles
in response to a single viral pathogen, LCMV. In nonlymphoid
organs such as the pancreas, iNKT cells promote an innate
response against LCMV by stimulating pDC functions. Then,
the resulting low viral titer in the pancreas attenuates the local
Figure 5. The OX40-OX40L Pathway Is Required for In Vitro pDC
and Pancreatic iNKT Cell Cooperation
Sorted pDCs (105 cells) from the spleen of CD1d-WT (A) or CD1d-deficient
(B) mice were cultured alone or with sorted iNKT cells (104 cells) from the
spleen or pancreatic islets of Va14 Tg mice. In some wells, CpG-ODN
2216, LCMV Arm, OX40L mAb, or OX40-Ig was added. Supernatants
were harvested after 36 hr of culture, and IFN-a production was measured
by ELISA. Results are the mean ± SD of the values obtained in 3–4 inde-
pendent experiments. Asterisk indicates p < 0.05 between culture condi-
tions, as indicated in the figure.
adaptive anti-LCMV CD8+ T cell response, thereby prevent-
ing insulitis and hyperglycemia in a model of virus-induced
diabetes.
A consensus model of the function of iNKT cells during
bacterial and virus infection is based on their production of
IFN-g and crosstalk with conventional DC (cDC) and NK cells
(Bendelac et al., 2006; Brigl and Brenner, 2004; Tupin et al.,
2007; Van Kaer, 2007). The present study reveals an unrec-
ognized mechanism used by iNKT cells to control viral infec-
tion. Indeed, upon LCMV infection, in the absence of iNKT
cell manipulation, iNKT cells are crucial for the recruitment
of pDCs, which are major players during viral infections. After
LCMV infection, the pDC frequency remained very low in the
pancreas of CD1d-deficient and Ja18-deficient mice as
compared to WT mice. Conversely, enhanced iNKT cell func-
tion, in transgenic mice or induced by a-GalCer-treatment,
further enhanced pDC recruitment in the pancreas. More-
over, iNKT cells promoted the activities of pDCs, as shown
by the stronger production of type I IFNs that inhibit LCMV
replication (Biron, 2001). The rapid inhibition of pancreatic
viral replication, observed as early as day 1,
is consistent with the innate immune function of both iNKT cells
and pDCs (Barchet et al., 2005; Van Kaer, 2007). The critical
role of pDCs in controlling pancreatic LCMV load was demon-
strated in depletion experiments with mAb 120G8. Previous
studies showed that mice treated with this mAb are specifically
depleted of pDCs, identified as B220hi Ly6Chi CD11clo cells or
mPDCA-1+ CD11c+ cells (Asselin-Paturel et al., 2003; Smit
et al., 2006). In contrast to the cooperation between iNKT cells
and pDCs in the pancreas, iNKT cells in the spleen did not influ-
ence pDC function or LCMV replication. The lack of an iNKT
cell effect on the splenic LCMV titer is in keeping with the results
of previous studies (Spence et al., 2001).
We then investigated the molecular basis of the specific inter-
action between iNKT cells and pDCs in pancreatic islets. We
found, for the first time, a critical role of OX40-OX40L interaction
in the enhancement of pDC functions by iNKT cells in vivo. At
steady state, OX40 was strongly expressed on iNKT cells from
the pancreas and liver but not from lymphoid organs, such as
the spleen and PLN. In addition, LCMV infection further
increased OX40 expression on iNKT cells from the pancreas
and liver, whereas this expression remained low in both the
spleen and PLN. In keeping with the tissue specificity of OX40
expression by iNKT cells, early LCMV replication was strongly
inhibited in the pancreas and liver but not in the spleen. The criti-
cal role of OX40-expressing iNKT cells was further confirmed
by cell-transfer experiments. Transfer of WT iNKT cells into294 Immunity 30, 289–299, February 20 , 2009 ª2009 Elsevier Inc.
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fer with OX40-deficient iNKT cells. Moreover, in vitro experi-
ments with sorted iNKT cells from the pancreas or spleen and
sorted pDCs showed that only pancreatic iNKT cells were able
to interact with pDCs and to induce type I IFN production upon
LCMV infection. Finally, blocking experiments, in vivo and
in vitro, with OX40L mAb and OX40-Ig clearly demonstrated
that the OX40-OX40L pathway was necessary for efficient
iNKT cell-pDC cooperation. The iNKT cell-pDC interaction might
induce reverse signaling through OX40L, as previously
described in human DCs (Ohshima et al., 1997) and other cell
types, such as B cells and vascular endothelial cells (Kotani
et al., 2002; Stuber et al., 1995). Alternatively, pDC-iNKT cell
interaction could lead to OX40-mediated activation of iNKT cells
(Marschner et al., 2005; Montoya et al., 2006; Zaini et al., 2007),
and this could in turn have positive feedback effect on pDCs. Of
note, iNKT cells had a slightly more activated phenotype in the
pancreas than in lymphoid tissues upon LCMV infection, but
we detected no cytokine production by pancreatic iNKT cells.
Figure 6. iNKT Cells and pDCs Dampen the Anti-
LCMV CD8+ T Cell Response in the Pancreas
(A) Analysis of NP396-specific CD8
+ T cells after LCMV Arm
challenge. Splenocytes and pancreatic islet cells were
recovered 8 days and 12 days, respectively, after infection
of control and Va14 Tg mice, expressing or not expressing
NP in the pancreas, as indicated. Cells were cultured for
4 hr with NP396 peptide and stained for intracellular IFN-g.
No IFN-g expression by CD8+ T cells was observed in the
absence of NP396 peptide stimulation (data not shown).
(B) Absolute numbers are represented by histograms. The
results correspond to the mean ± SD of the values
obtained in 3–5 independent experiments, each per-
formed with three pooled mice. Asterisk indicates p <
0.05, compared to control mice.
(C) Pancreatic NP396-specific CD8
+ T cell response on day
12 after LCMV Arm challenge of Ins-NP control mice
injected with 8.5 3 106 iNKT cells two days prior to infec-
tion. The results correspond to the mean ± SD of the
values obtained in two experiments, each performed
with two pooled mice per group.
(D) Pancreatic NP396-specific CD8
+ T cell response
12 days after LCMV Arm challenge of Ins-NP mice treated
or untreated with mAb 120G8 or OX40L mAb. Results
correspond to the mean of the values obtained in three
independent experiments, with three pooled mice for
each group. Asterisk indicates p < 0.05 compared to
untreated mice.
(E) Pancreatic viral titer on day 3 and pancreatic anti-NP396
CD8+ T cell response on day 12 in control and Va14 Tg Ins-
NP mice challenged with LCMV Arm inocula of 104, 105, or
106 pfu. Results correspond to the mean of the values
obtained in 3–6 independent experiments, with three
pooled mice for each group. Asterisk indicates p < 0.05,
compared to 105 pfu.
Interestingly, the reduced frequency of iNKT
cells observed upon LCMV infection could be
due to TCR downregulation as a result of activa-
tion; alternatively, LCMV infection could result in
activation-induced cell death of iNKT cells, as
previously suggested (Hobbs et al., 2001).
In contrast to OX40, CD1d was not required for iNKT cell-pDC
cooperation, as shown in vitro with CD1d-deficient pDCs. CD1d
was also nonessential for the prevention of LCMV-induced
diabetes by iNKT cells. Va14 Tg Ins-NP mice expressing CD1d
exclusively in the thymus, as a transgene (Novak et al., 2007),
remained free of diabetes upon LCMV infection (data not shown).
Our analysis of the interaction between iNKT cells and pDCs also
showed that IFN-g was nonessential, because treatment with an
IFN-g blocking mAb did not influence type I IFN production by
pancreatic pDCs. Together, these in vitro and in vivo experi-
ments suggest that interactions between iNKT cells and different
DC subsets might involve distinct molecules, given that CD1d
and IFN-g appear to participate in iNKT cell-cDC crosstalk
upon activation with TLR ligands (Brigl et al., 2003; Paget
et al., 2007; Salio et al., 2007), whereas our study shows the crit-
ical role of OX40-OX40L molecules in iNKT cell-pDC interaction.
The different iNKT cell-mediated effects in the pancreas and
spleen could be a result of their interactions with various DC
subsets. Instead of pDCs, cDCs might be the main cellularImmunity 30, 289–299, February 20 , 2009 ª2009 Elsevier Inc. 295
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responses. This is supported by the increased IL-12 production
by splenic cDCs in LCMV-infected Va14 Tg mice, as compared
to control mice (data not shown). Given the role of IL-12 in adap-
tive antiviral responses (Trinchieri, 2003), enhanced IL-12
production could explain the exacerbated splenic anti-LCMV
CD8+ T cell responses in a-GalCer-treated mice and Va14 Tg
mice. Thus, crosstalk between iNKT cells and various DC
subsets in different tissues might induce different immune
responses.
Cooperation between iNKT cells and pDCs in the pancreas
upon viral infection could have major implications for host tissue
integrity. The amplified pancreatic pDC activities by iNKT cells
dampened the local anti-LCMV CD8+ T cell response and the
subsequent hyperglycemia in transgenic Ins-NP mice. Previous
studies of the role of iNKT cells in the response to diabetogenic
EMCV showed that CD1d-deficient mice have higher viral titers
and a higher incidence of hyperglycemia; however, the CD1d-
restricted T cells were not iNKT cells and the mechanisms
involved remain unclear (Exley et al., 2003; Exley et al., 2001).
Our study reveals a mechanism by which iNKT cells reduce
Figure 7. iNKT Cells and pDCs Prevent
Tissue Damage after LCMV Infection of
Ins-NP Mice
(A) An insulitis score was determined for pancre-
atic sections on days 13–20 after infection with
105 pfu of LCMV Arm. The bars correspond to
the means of each group of six mice. Hematox-
ylin-eosin staining was performed on pancreatic
sections from Ins-NP mice 12 days after 105 pfu
LCMV Arm infection (X100).
(B) Incidence of hyperglycemia after infection of
control, Va14 Tg, a-GalCer-treated, or CD1d-
deficient Ins-NP mice with 105 pfu (left panel) or
104 pfu (right panel) of LCMV Arm.
(C) Incidence of hyperglycemia after infection of
control, Va14 Tg, and a-GalCer-treated Ins-NP
mice after treatment with OX40L or 120G8
mAbs. The log-rank test was used for comparison
of diabetes incidence rates. Asterisk indicates
p < 0.05, compared to control mice (B) or untreated
mice (C).
pancreatic LCMV titers through local
pDC cooperation. Moreover, we show
that pancreatic virus load has a major
influence on the local induction of anti-
NP396 CD8
+ T cell responses leading to
pancreatic injury. The role of pancreatic
viral load in the anti-NP396 CD8
+ T cell
response was further demonstrated by
inoculation of a range of LCMV doses.
Infection of Ins-NP mice with a low viral
dose (103 pfu) induced a weak pancreatic
anti-LCMV CD8+ T cell response and no
hyperglycemia (data not shown). The
link between early inhibition of pancreatic
viral replication and protection against
diabetes was further suggested by the
failure of late a-GalCer treatment (day 6) to prevent diabetes
(data not shown).
Collectively, our data reveal that iNKT cells can control early
viral replication by cooperating with pDCs in a tissue-specific
manner. These findings might have broad implications for human
diseases, given the suspected role of viral infections in various
pathological situations (von Herrath et al., 2003) and the marked
interindividual differences in human iNKT cell frequencies (Lee
et al., 2002). Of note, SAP- or XIAP-deficient patients harboring
very low frequencies of iNKT cells develop severe Epstein-Barr
virus infection associated with deleterious inflammation (Rigaud
et al., 2006). Finally, our data suggest that exogenous stimulation
of iNKT cells might help to prevent virus-induced diseases by
promoting pDC antiviral responses.
EXPERIMENTAL PROCEDURES
Mice and Treatments
Va14 Tg NOD mice and Ins-NP NOD mice were generated directly by transgen-
esis of NOD eggs (Beaudoin et al., 2002; Laloux et al., 2001; Martinic et al.,
2007). CD1d-deficient and Ja18-deficient NOD mice had been generated by
backcross (>15) onto NOD mice (Mendiratta et al., 1997; Zhu et al., 2007).296 Immunity 30, 289–299, February 20 , 2009 ª2009 Elsevier Inc.
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tions. Mice were used at 6–8 weeks of age. When indicated, mice were injected
i.p. with a-GalCer (2 mg/mouse) on the day of infection (day 0); with 1 mg of
depleting 120G8 mAb per mouse on days 1, 1, and 3, with neutralizing
IFN-g mAb (R46A2) on days 1 and 1, or with 0.5 mg of neutralizing OX40L
mAb (OX89) per mouse on days 1, 1, and 3. This study was approved by
the local ethics committee on animal experimentation.
Virus
LCMV Armstrong (Arm) clone 53b stocks (Oldstone et al., 1991) were prepared
by a single passage on baby hamster kidney (BHK)-21 cells. Some experi-
ments were performed with LCMV strain WE obtained from G. de Saint-Basile
(Hoˆpital Necker, Paris), stocks being prepared by a single passage on L929
cells. In some experiments, animals were infected i.p. with a single dose of
103, 104, or 106 pfu. LCMV titers were measured through observation of plaque
formation on Vero cells. The spleen, pancreas, and liver were frozen at –80C,
thawed, and homogenized. Log dilutions of supernatants were added to Vero
cell monolayers. The plates were incubated at 37C, then stained 5 days later
with crystal violet after fixation. Experimental samples were run in parallel with
LCMV standards and negative controls.
Hyperglycemia Diagnosis and Histology
Overt diabetes was defined by two consecutive positive glucosuria tests and
glycemia > 200 mg/dl. Insulitis was evaluated on 4 mm sections of pancreas
stained with hematoxylin-eosin. At least 40 islets per mouse were scored.
Peri-insulitis was recorded when islets were surrounded by inflammatory cells,
and insulitis was recorded when inflammatory cells invaded islets.
Preparation of Pancreatic Islet Cells
Mice were sacrificed, and the pancreas was perfused with 3 ml of a solution
containing 1.5 mg/mL of collagenase P (Roche), then dissected free from
surrounding lymph nodes. The pancreas was digested at 37C for 10 min,
and the islets were then purified on a Ficoll gradient and dissociated with
a nonenzymatic cell-dissociation solution (Sigma).
Coculture of Sorted pDCs and iNKT Cells
iNKT cells were sorted as cells double-positive for TCR-b mAb and CD1d:
a-GalCer tetramers, with the use of a FacsAria cell sorter (Becton Dickinson).
pDCs were purified with the PanDC selection kit (Milteniy Biotech) and sorting
of 120G8highCD11clow cells. The purity of sorted cell populations was > 95%.
Culture was performed in 200 ml of complete RPMI medium with 20 ng/mL
a-GalCer. In some wells, 105 pfu of LCMV, 10 mg/mL CpG, 100 mg/mL neutral-
izing OX40L mAb (OX89), or 100 mg/mL soluble mouse OX40-Ig (Curry et al.,
2004) was added to the culture.
Adoptive Transfer of iNKT cells
Spleen iNKT cells were isolated from Va14 Tg C57BL/6 mice or Va14 Tg
OX40-deficient C57BL/6 mice by negative selection with the Dynal mouse
CD4 negative isolation kit, followed by positive selection of CD1d:a-GalCer
tetramer-positive cells. The purity of isolated cell populations was > 95%.
OX40-deficient C57BL/6 mice (eight backcrosses onto C57BL/6 mice) (Kopf
et al., 1999) were treated with PK136 mAb (0.5 mg/mouse) for the depletion
of NK cells (Figure S7) and the promotion of iNKT cell adoptive transfer. One
week later, these mice were reconstituted with 5 3 106 iNKT cells expressing
or not expressing OX40, and they were then infected with LCMV two days
later. The same protocol was used for the transfer of 8.5 3 105 iNKT cells
from Va14 Tg NOD mice into Ins-NP NOD control mice.
Flow Cytometry
Cells were stained at 4C in PBS containing 2% FCS and 0.1% azide after
FcgR was blocked with mAb 2.4G2. Surface staining was performed with
CD8 (53-6.7), TCR-b (H57), CD69 (H1.2F3), CD25 (PC61), CD19 (1D3), CD44
(IM7), CD45 (30-F11), CD11b (M1/70), Siglec-H (440c), and CD11c (HL3), all
from BD PharMingen. mAb mPDCA1 was from Milteniy, and mAb 120G8
was Fitc-conjugated in the laboratory. OX40 (OX86) and OX40L (RM134L)
mAbs were from eBioscience. Biotinylated goat anti-rat IgG was from Jackson
Immuno Research Laboratories, and purified rat anti-mouse IFN-a (clone F18
or clone RMMA-1) and anti-IFN-b (clone RMMB-1) were from Tebu-bio. Intra-cellular staining of type I IFN in pDCs was performed as previously described
(Sjolin et al., 2006). a-GalCer-CD1d tetramers were prepared as previously
described (Novak et al., 2007). For IFN-g (XMG1.2; BD PharMingen) intracel-
lular staining of CD8 T cells, single-cell suspensions were stimulated with
1 mg/ml viral NP396-404 peptide for 4 hr at 37
C in the presence of 10 U/ml
mouse rIL-2 and 1 mg/ml Brefeldin A (Sigma). Stained cells were analyzed on
a FACSCalibur flow cytometer (BD Biosciences).
Statistical Analysis
Statistical analysis was performed with the nonparametric Mann-Whitney U
test. The log-rank test was used for the comparison of diabetes incidence
rates. Reported values are means ± SD as indicated. p values below 0.05
were considered as representing statistically significant differences. All data
were analyzed with GraphPad Prism v5 software.
SUPPLEMENTAL DATA
Supplemental Data include seven figures and can be found with this article
online at http://www.immunity.com/supplemental/S1074-7613(09)00071-5.
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